CEN/TS 17390-2:2020

Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for circulating tumor cells (CTCs) in venous whole blood - Part 2: Isolated DNA CEN/TS 17390-2:2020

Publication date:   Aug 17, 2020

General information

99.60 Withdrawal effective   Nov 13, 2024

CEN

CEN/TC 140 In vitro diagnostic medical devices

Technical Specification

11.100.10   In vitro diagnostic test systems

Buying

Published

Language in which you want to receive the document.

Scope

This document gives guidelines on the handling, storage, processing and documentation of venous blood
specimens intended for the examination of human genomic DNA isolated from Circulating Tumor Cells (CTCs) during the pre-examination phase before a molecular examination is performed.
This document is applicable to molecular in vitro diagnostic examinations including laboratory developed tests performed by medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organizations performing biomedical research, and regulatory authorities.
This document does not cover the isolation of specific blood cells and subsequent isolation of genomic DNA therefrom.
DNA in pathogens present in blood is not covered by this document.
NOTE International, national or regional regulations or requirements can also apply to specific topics covered in this document.

Life cycle

NOW

WITHDRAWN
CEN/TS 17390-2:2020
99.60 Withdrawal effective
Nov 13, 2024

REVISED BY

PUBLISHED
CEN ISO/TS 7552-2:2024